The National Institutes of Health (NIH) is offering a grant opportunity to support groundbreaking R01 research projects focusing on HIV/AIDS and substance abuse. This grant complements the Avant-Garde and Avenir Award Programs, encouraging innovative approaches to HIV/AIDS and drug use research. Applicants must provide detailed research plans and preliminary data, emphasizing the potential to advance HIV/AIDS prevention and treatment for substance abusers. Both individual researchers and teams are welcome to apply, with a requirement to address the connection between HIV/AIDS and drug abuse. Applications should align with NIH HIV/AIDS Research Priorities. Deadline for submission is August 21, 2020.
Opportunity ID: 301634
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-18-022 |
Funding Opportunity Title: | Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 14, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Aug 21, 2020 |
Current Closing Date for Applications: | Aug 21, 2020 |
Archive Date: | Sep 26, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Independent school districts County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Small businesses For profit organizations other than small businesses City or township governments Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This FOA supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. The Avant-Garde award supports individuals who conduct high-risk, high-reward research and does not require a detailed research plan. The Avenir award is similar to the Avant-Garde award but focuses on support for early stage investigators. Applications submitted under this FOA are required to have a detailed research plan and preliminary data. This FOA focuses on innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among substance abusers. The nexus with drug abuse should be clearly described. This FOA is open to both individual researchers and research teams and is not limited to any one area of research on HIV and substance use, but all studies must focus on NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-022.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00239178 | Jul 22, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259267 | Jul 22, 2018 | Aug 21, 2020 | View |
Package 1
Mandatory forms
301634 RR_SF424_2_0-2.0.pdf
301634 PHS398_CoverPageSupplement_4_0-4.0.pdf
301634 RR_OtherProjectInfo_1_4-1.4.pdf
301634 PerformanceSite_2_0-2.0.pdf
301634 RR_KeyPersonExpanded_2_0-2.0.pdf
301634 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
301634 RR_Budget_1_4-1.4.pdf
301634 RR_SubawardBudget30_1_4-1.4.pdf
301634 PHS398_ModularBudget_1_2-1.2.pdf
301634 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
301634 RR_SF424_2_0-2.0.pdf
301634 PHS398_CoverPageSupplement_5_0-5.0.pdf
301634 RR_OtherProjectInfo_1_4-1.4.pdf
301634 PerformanceSite_2_0-2.0.pdf
301634 RR_KeyPersonExpanded_2_0-2.0.pdf
301634 PHS398_ResearchPlan_4_0-4.0.pdf
301634 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
301634 RR_Budget_1_4-1.4.pdf
301634 RR_SubawardBudget30_1_4-1.4.pdf
301634 PHS398_ModularBudget_1_2-1.2.pdf
301634 PHS_AssignmentRequestForm_3_0-3.0.pdf